Amedeo Smart

Free Medical Literature Service


 

Amedeo

COVID-19

  Free Subscription

Articles published in
J Virol
    September 2021
  1. TOSTANOSKI LH, Gralinski LE, Martinez DR, Schaefer A, et al
    Protective efficacy of rhesus adenovirus COVID-19 vaccines against mouse-adapted SARS-CoV-2.
    J Virol. 2021 Sep 15:JVI0097421. doi: 10.1128/JVI.00974.
    >> Share

  2. NILSSON-PAYANT BE, Uhl S, Grimont A, Doane AS, et al
    The NF-kappaB transcriptional footprint is essential for SARS-CoV-2 replication.
    J Virol. 2021 Sep 15:JVI0125721. doi: 10.1128/JVI.01257.
    >> Share

  3. CHEN HY, Huang C, Tian L, Huang X, et al
    Cytoplasmic tail truncation of SARS-CoV-2 Spike protein enhances titer of pseudotyped vectors but masks the effect of the D614G mutation.
    J Virol. 2021 Sep 8:JVI0096621. doi: 10.1128/JVI.00966.
    >> Share

  4. CHIEM K, Morales Vasquez D, Silvas JA, Park JG, et al
    A bifluorescent-based assay for the identification of neutralizing antibodies against SARS-CoV-2 variants of concern in vitro and in vivo.
    J Virol. 2021 Sep 8:JVI0112621. doi: 10.1128/JVI.01126.
    >> Share

  5. ANDRADE ACDSP, Gabriel Campolina-Silva H, Queiroz-Junior CM, de Oliveira LC, et al
    A biosafety level-2 mouse model for studying betacoronavirus-induced acute lung damage and systemic manifestations.
    J Virol. 2021 Sep 8:JVI0127621. doi: 10.1128/JVI.01276.
    >> Share

    August 2021
  6. LI X, Wang L, Liu P, Li H, et al
    A novel potentially recombinant rodent coronavirus with a polybasic cleavage site in the spike protein.
    J Virol. 2021 Aug 25:JVI0117321. doi: 10.1128/JVI.01173.
    >> Share

  7. SHILIAEV N, Lukash T, Palchevska O, Crossman DK, et al
    Natural isolate and recombinant SARS-CoV-2 rapidly evolve in vitro to higher infectivity through more efficient binding to heparan sulfate and reduced S1/S2 cleavage.
    J Virol. 2021 Aug 18:JVI0135721. doi: 10.1128/JVI.01357.
    >> Share

  8. YANG YL, Liu J, Wang TY, Chen M, et al
    Aminopeptidase N is an entry co-factor triggering porcine deltacoronavirus entry via an endocytotic pathway.
    J Virol. 2021 Aug 18:JVI0094421. doi: 10.1128/JVI.00944.
    >> Share

  9. WANG G, Hu G, Liang R, Shi J, et al
    Establishment of Full-length cDNA Clones and an Efficient Oral Infection Model for Feline Coronavirus in Cats.
    J Virol. 2021 Aug 18:JVI0074521. doi: 10.1128/JVI.00745.
    >> Share

  10. KREUTZBERGER AJB, Sanyal A, Ojha R, Pyle JD, et al
    Synergistic block of SARS-CoV-2 infection by combined drug inhibition of the host entry factors PIKfyve kinase and TMPRSS2 protease.
    J Virol. 2021 Aug 18:JVI0097521. doi: 10.1128/JVI.00975.
    >> Share

  11. LU M, Zhang Y, Dravid P, Li A, et al
    A methyltransferase-defective VSV-based SARS-CoV-2 vaccine candidate provides complete protection against SARS-CoV-2 infection in hamsters.
    J Virol. 2021 Aug 11:JVI0059221. doi: 10.1128/JVI.00592.
    >> Share

    July 2021
  12. CANTWELL AM, Singh H, Platt M, Yu Y, et al
    Kinetic multi-omic analysis of responses to SARS-CoV-2 infection in a model of severe COVID-19.
    J Virol. 2021 Jul 28:JVI0101021. doi: 10.1128/JVI.01010.
    >> Share

  13. LI Z, Gao F, Lan Y, Guan J, et al
    Porcine Haemagglutinating Encephalomyelitis Virus Triggers Neural Autophagy Independent of ULK1.
    J Virol. 2021 Jul 21:JVI0085121. doi: 10.1128/JVI.00851.
    >> Share

  14. WANG H, Kong N, Jiao Y, Dong S, et al
    EGR1 suppresses porcine epidemic diarrhea virus replication by regulating IRAV to degrade viral nucleocapsid protein.
    J Virol. 2021 Jul 21:JVI0064521. doi: 10.1128/JVI.00645.
    >> Share

  15. FERRARI M, Mekkaoui L, Ilca FT, Akbar Z, et al
    Characterisation of a novel ACE2-based therapeutic with enhanced rather than reduced activity against SARS-CoV-2 variants.
    J Virol. 2021 Jul 21:JVI0068521. doi: 10.1128/JVI.00685.
    >> Share

  16. CHEN DY, Khan N, Close BJ, Goel RK, et al
    SARS-CoV-2 disrupts proximal elements in the JAK-STAT pathway.
    J Virol. 2021 Jul 14:JVI0086221. doi: 10.1128/JVI.00862.
    >> Share

  17. XU J, Mao J, Han X, Shi F, et al
    Porcine epidemic diarrhea virus inhibits HDAC1 expression to facilitate its replication via binding of its nucleocapsid protein to host transcription factor Sp1.
    J Virol. 2021 Jul 7:JVI0085321. doi: 10.1128/JVI.00853.
    >> Share

    June 2021
  18. NGUYEN HT, Falzarano D, Gerdts V, Liu Q, et al
    Construction of a non-infectious SARS-CoV-2 replicon for antiviral drug testing and gene function studies.
    J Virol. 2021 Jun 30:JVI0068721. doi: 10.1128/JVI.00687.
    >> Share

  19. SUN G, Sui Y, Zhou Y, Ya J, et al
    Structural basis of covalent inhibitory mechanism of TMPRSS2-related serine proteases by camostat.
    J Virol. 2021 Jun 23:JVI0086121. doi: 10.1128/JVI.00861.
    >> Share

  20. MEYER K, Patra T, Vijayamahantesh, Ray R, et al
    SARS-CoV-2 spike protein induces paracrine senescence and leukocyte adhesionin endothelial cells.
    J Virol. 2021 Jun 23:JVI0079421. doi: 10.1128/JVI.00794.
    >> Share

  21. SILVAS JA, Morales Vasquez D, Park JG, Chiem K, et al
    Contribution of SARS-CoV-2 accessory proteins to viral pathogenicity in K18 hACE2 transgenic mice.
    J Virol. 2021 Jun 16:JVI0040221. doi: 10.1128/JVI.00402.
    >> Share

  22. LI A, Zhao K, Zhang B, Hua R, et al
    SARS-CoV-2 NSP12 protein is not an IFN-beta antagonist.
    J Virol. 2021 Jun 16:JVI0074721. doi: 10.1128/JVI.00747.
    >> Share

  23. KUMAR A, Ishida R, Strilets T, Cole J, et al
    SARS-CoV-2 Nonstructural Protein 1 Inhibits the Interferon Response by Causing Depletion of Key Host Signaling Factors.
    J Virol. 2021;95:e0026621.
    >> Share

  24. HAYASHI Y, Tsuchiya K, Yamamoto M, Nemoto-Sasaki Y, et al
    N-(4-Hydroxyphenyl) retinamide suppresses SARS-CoV-2 spike protein-mediated cell-cell fusion by a dihydroceramide Delta4-desaturase 1-independent mechanism.
    J Virol. 2021 Jun 9:JVI0080721. doi: 10.1128/JVI.00807.
    >> Share

  25. WANG X, Zhao Y, Yan F, Wang T, et al
    Viral and host transcriptomes in SARS-CoV-2 infected human lung cells.
    J Virol. 2021 Jun 9:JVI0060021. doi: 10.1128/JVI.00600.
    >> Share

  26. OU J, Zhou Z, Dai R, Zhang J, et al
    V367F mutation in SARS-CoV-2 spike RBD emerging during the early transmission phase enhances viral infectivity through increased human ACE2 receptor binding affinity.
    J Virol. 2021 Jun 2:JVI0061721. doi: 10.1128/JVI.00617.
    >> Share

    May 2021
  27. SU M, Shi D, Xing X, Qi S, et al
    Coronavirus PEDV nucleocapsid protein interacts with p53 to induce cell cycle arrest in S-phase and promotes viral replication.
    J Virol. 2021 May 26:JVI0018721. doi: 10.1128/JVI.00187.
    >> Share

  28. LATOURRETTE K, Holste NM, Rodriguez-Pena R, Leme RA, et al
    Genome-wide variation in betacoronaviruses.
    J Virol. 2021 May 26:JVI0049621. doi: 10.1128/JVI.00496.
    >> Share

  29. DOSTALIK P, Krafcikova P, Silhan J, Kozic J, et al
    Structural analysis of the OC43 coronavirus 2'-O-RNA methyltransferase.
    J Virol. 2021 May 19. pii: JVI.00463-21. doi: 10.1128/JVI.00463.
    >> Share

  30. VOTH LS, O'Connor JJ, Kerr CM, Doerger E, et al
    Unique mutations in the MHV macrodomain differentially attenuate virus replication, indicating multiple roles for the macrodomain in coronavirus replication.
    J Virol. 2021 May 19. pii: JVI.00766-21. doi: 10.1128/JVI.00766.
    >> Share

  31. YAN B, Chakravorty S, Mirabelli C, Wang L, et al
    Host-virus chimeric events in SARS-CoV2 infected cells are infrequent and artifactual.
    J Virol. 2021 May 12. pii: JVI.00294-21. doi: 10.1128/JVI.00294.
    >> Share

  32. CARNELL GW, Ciazynska KA, Wells DA, Xiong X, et al
    SARS-CoV-2 spike protein stabilized in the closed state induces potent neutralizing responses.
    J Virol. 2021 May 7. pii: JVI.00203-21. doi: 10.1128/JVI.00203.
    >> Share

  33. TRIBOLET L, Alexander MR, Brice AM, van Vuren PJ, et al
    ILRUN downregulates ACE2 expression and blocks infection of human cells by SARS-CoV-2.
    J Virol. 2021 May 7. pii: JVI.00327-21. doi: 10.1128/JVI.00327.
    >> Share

  34. LULLA V, Wandel MP, Bandyra KJ, Ulferts R, et al
    Targeting the conserved stem loop 2 motif in the SARS-CoV-2 genome.
    J Virol. 2021 May 7. pii: JVI.00663-21. doi: 10.1128/JVI.00663.
    >> Share

  35. LEE W, Kingstad-Bakke B, Kedl RM, Kawaoka Y, et al
    CCR2 Regulates Vaccine-Induced Mucosal T-Cell Memory to Influenza A Virus.
    J Virol. 2021 May 5. pii: JVI.00530-21. doi: 10.1128/JVI.00530.
    >> Share

    April 2021
  36. RESNICK SJ, Iketani S, Hong SJ, Zask A, et al
    Inhibitors of coronavirus 3CL proteases protect cells from protease-mediated cytotoxicity.
    J Virol. 2021 Apr 28. pii: JVI.02374-20. doi: 10.1128/JVI.02374.
    >> Share

  37. ALFI O, Yakirevitch A, Wald O, Wandel O, et al
    Human nasal and lung tissues infected ex vivo with SARS-CoV-2 provide insights into differential tissue-specific and virus-specific innate immune responses in the upper and lower respiratory tract.
    J Virol. 2021 Apr 23. pii: JVI.00130-21. doi: 10.1128/JVI.00130.
    >> Share

  38. VIDAL SJ, Collier AY, Yu J, McMahan K, et al
    Correlates of Neutralization Against SARS-CoV-2 Variants of Concern by Early Pandemic Sera.
    J Virol. 2021 Apr 23. pii: JVI.00404-21. doi: 10.1128/JVI.00404.
    >> Share

  39. VERMA D, Mel Church T, Swaminathan S
    Epstein-Barr virus lytic replication induces ACE2 expression and enhances SARS CoV-2 pseudotyped virus entry in epithelial cells.
    J Virol. 2021 Apr 14. pii: JVI.00192-21. doi: 10.1128/JVI.00192.
    >> Share

  40. PATEL DR, Field CJ, Septer KM, Sim DG, et al
    Transmission and protection against re-infection in the ferret model with the SARS-CoV-2 USA-WA1/2020 reference isolate.
    J Virol. 2021 Apr 7. pii: JVI.02232-20. doi: 10.1128/JVI.02232.
    >> Share

    March 2021
  41. LIU W, Reyes HM, Yang JF, Li Y, et al
    Activation of STING signaling pathway effectively blocks human coronavirus infection.
    J Virol. 2021 Mar 31. pii: JVI.00490-21. doi: 10.1128/JVI.00490.
    >> Share

  42. TOMITA Y, Matsuyama S, Fukuhara H, Maenaka K, et al
    The physiological TMPRSS2 inhibitor HAI-2 alleviates SARS-CoV-2 infection.
    J Virol. 2021 Mar 31. pii: JVI.00434-21. doi: 10.1128/JVI.00434.
    >> Share

  43. MORA-DIAZ JC, Pineyro PE, Rauh R, Nelson W, et al
    Porcine hemagglutinating encephalomyelitis virus infection in vivo and ex vivo.
    J Virol. 2021 Mar 24. pii: JVI.02335-20. doi: 10.1128/JVI.02335.
    >> Share

  44. YU J, Li Z, He X, Gebre MS, et al
    Deletion of the SARS-CoV-2 Spike Cytoplasmic Tail Increases Infectivity in Pseudovirus Neutralization Assays.
    J Virol. 2021 Mar 16. pii: JVI.00044-21. doi: 10.1128/JVI.00044.
    >> Share

  45. CHENG J, Zhao Y, Hu Y, Zhao J, et al
    The furin-S2' site in avian coronavirus plays a key role in central nervous system damage progression.
    J Virol. 2021 Mar 16. pii: JVI.02447-20. doi: 10.1128/JVI.02447.
    >> Share

  46. MA J, Su D, Sun Y, Huang X, et al
    Cryo-EM structure of S-Trimer, a subunit vaccine candidate for COVID-19.
    J Virol. 2021 Mar 10. pii: JVI.00194-21. doi: 10.1128/JVI.00194.
    >> Share

  47. ZHANG Y, Huang K, Wang T, Deng F, et al
    SARS-CoV-2 rapidly adapts in aged BALB/c mice and induces typical pneumonia.
    J Virol. 2021 Mar 10. pii: JVI.02477-20. doi: 10.1128/JVI.02477.
    >> Share

  48. PALMER MV, Martins M, Falkenberg S, Buckley A, et al
    Susceptibility of white-tailed deer (Odocoileus virginianus) to SARS-CoV-2.
    J Virol. 2021 Mar 10. pii: JVI.00083-21. doi: 10.1128/JVI.00083.
    >> Share

  49. JACOB-DOLAN C, Feldman J, McMahan K, Yu J, et al
    Coronavirus-Specific Antibody Cross Reactivity in Rhesus Macaques Following SARS-CoV-2 Vaccination and Infection.
    J Virol. 2021 Mar 10. pii: JVI.00117-21. doi: 10.1128/JVI.00117.
    >> Share

  50. LIU S, Selvaraj P, Lien CZ, Nunez IA, et al
    The PRRA insert at the S1/S2 site modulates cellular tropism of SARS-CoV-2 and ACE2 usage by the closely related Bat RaTG13.
    J Virol. 2021 Mar 8. pii: JVI.01751-20. doi: 10.1128/JVI.01751.
    >> Share

  51. MA H, Zeng W, Meng X, Huang X, et al
    Potent Neutralization of SARS-CoV-2 by Hetero-bivalent Alpaca Nanobodies Targeting the Spike Receptor-Binding Domain.
    J Virol. 2021 Mar 3. pii: JVI.02438-20. doi: 10.1128/JVI.02438.
    >> Share

  52. VOLOCH CM, da Silva Francisco R Jr, de Almeida LGP, Cardoso CC, et al
    Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil.
    J Virol. 2021 Mar 1. pii: JVI.00119-21. doi: 10.1128/JVI.00119.
    >> Share

    February 2021
  53. DEINHARDT-EMMER S, Bottcher S, Haring C, Giebeler L, et al
    SARS-CoV-2 causes severe epithelial inflammation and barrier dysfunction.
    J Virol. 2021 Feb 26. pii: JVI.00110-21. doi: 10.1128/JVI.00110.
    >> Share

  54. LE COUPANEC A, Desforges M, Kaufer B, Dubeau P, et al
    Potential differences in cleavage of the S protein and type-1 interferon together control human coronavirus infection, propagation, and neuropathology within the central nervous system.
    J Virol. 2021 Feb 24. pii: JVI.00140-21. doi: 10.1128/JVI.00140.
    >> Share

  55. DHAKAL S, Loube J, Misplon JA, Lo CY, et al
    Effect of an adenovirus-vectored universal influenza virus vaccine on pulmonary pathophysiology in a mouse model.
    J Virol. 2021 Feb 24. pii: JVI.02359-20. doi: 10.1128/JVI.02359.
    >> Share

  56. DE VRIES M, Mohamed AS, Prescott RA, Valero-Jimenez AM, et al
    A comparative analysis of SARS-CoV-2 antivirals characterizes 3CL(pro) inhibitor PF-00835231 as a potential new treatment for COVID-19.
    J Virol. 2021 Feb 23. pii: JVI.01819-20. doi: 10.1128/JVI.01819.
    >> Share

  57. HORNICH BF, Grosskopf AK, Schlagowski S, Tenbusch M, et al
    SARS-CoV-2 and SARS-CoV spike-mediated cell-cell fusion differ in the requirements for receptor expression and proteolytic activation.
    J Virol. 2021 Feb 19. pii: JVI.00002-21. doi: 10.1128/JVI.00002.
    >> Share

  58. SUN L, Chen H, Ming X, Bo Z, et al
    Porcine Epidemic Diarrhea Virus Infection Induces Caspase-8 mediated G3BP1 Cleavage and Subverts Stress Granules to Promote Viral Replication.
    J Virol. 2021 Feb 10. pii: JVI.02344-20. doi: 10.1128/JVI.02344.
    >> Share

  59. WINSTONE H, Lista MJ, Reid AC, Bouton C, et al
    The polybasic cleavage site in the SARS-CoV-2 spike modulates viral sensitivity to Type I interferon and IFITM2.
    J Virol. 2021 Feb 9. pii: JVI.02422-20. doi: 10.1128/JVI.02422.
    >> Share

    January 2021
  60. REBENDENNE A, Valadao ALC, Tauziet M, Maarifi G, et al
    SARS-CoV-2 triggers an MDA-5-dependent interferon response which is unable to control replication in lung epithelial cells.
    J Virol. 2021 Jan 29. pii: JVI.02415-20. doi: 10.1128/JVI.02415.
    >> Share

  61. DAGOTTO G, Mercado NB, Martinez DR, Hou YJ, et al
    Comparison of Subgenomic and Total RNA in SARS-CoV-2 Challenged Rhesus Macaques.
    J Virol. 2021 Jan 20. pii: JVI.02370-20. doi: 10.1128/JVI.02370.
    >> Share

  62. DOMINGO E, Perales C
    The time for COVID-19 vaccination.
    J Virol. 2021 Jan 19. pii: JVI.02437-20. doi: 10.1128/JVI.02437.
    >> Share

  63. CHEN JS, Alfajaro MM, Chow RD, Wei J, et al
    Non-steroidal anti-inflammatory drugs dampen the cytokine and antibody response to SARS-CoV-2 infection.
    J Virol. 2021 Jan 13. pii: JVI.00014-21. doi: 10.1128/JVI.00014.
    >> Share

  64. CHIEM K, Morales Vasquez D, Park JG, Platt RN, et al
    Generation and Characterization of recombinant SARS-CoV-2 expressing reporter genes.
    J Virol. 2021 Jan 11. pii: JVI.02209-20. doi: 10.1128/JVI.02209.
    >> Share

  65. SHI Y, Shi J, Sun L, Tan Y, et al
    Insight into vaccine development for Alpha-coronaviruses based on structural and immunological analyses of spike proteins.
    J Virol. 2021 Jan 7. pii: JVI.02284-20. doi: 10.1128/JVI.02284.
    >> Share

  66. GARCIA-ARRIAZA J, Garaigorta U, Perez P, Lazaro-Frias A, et al
    COVID-19 vaccine candidates based on modified vaccinia virus Ankara expressing the SARS-CoV-2 spike induce robust T- and B-cell immune responses and full efficacy in mice.
    J Virol. 2021 Jan 7. pii: JVI.02260-20. doi: 10.1128/JVI.02260.
    >> Share

    December 2020
  67. ZHAO J, Sun L, Zhao Y, Feng D, et al
    Coronavirus Endoribonuclease Ensures Efficient Viral Replication and Prevents Protein Kinase R Activation.
    J Virol. 2020 Dec 23. pii: JVI.02103-20. doi: 10.1128/JVI.02103.
    >> Share

  68. LEE E, Sandgren K, Duette G, Stylianou VV, et al
    Identification of SARS-CoV-2 Nucleocapsid and Spike T-cell Epitopes for Assessing T-cell Immunity.
    J Virol. 2020 Dec 21. pii: JVI.02002-20. doi: 10.1128/JVI.02002.
    >> Share

  69. NGUYEN HT, Zhang S, Wang Q, Anang S, et al
    Spike glycoprotein and host cell determinants of SARS-CoV-2 entry and cytopathic effects.
    J Virol. 2020 Dec 11. pii: JVI.02304-20. doi: 10.1128/JVI.02304.
    >> Share

  70. TAKAGI A, Matsui M
    Identification of HLA-A*02:01-restricted candidate epitopes derived from the non-structural polyprotein 1a of SARS-CoV-2 that may be natural targets of CD8(+) T cell recognition in vivo.
    J Virol. 2020 Dec 2. pii: JVI.01837-20. doi: 10.1128/JVI.01837.
    >> Share

  71. TAVARES RCA, Mahadeshwar G, Wan H, Huston NC, et al
    The global and local distribution of RNA structure throughout the SARS-CoV-2 genome.
    J Virol. 2020 Dec 2. pii: JVI.02190-20. doi: 10.1128/JVI.02190.
    >> Share

    November 2020
  72. PAHMEIER F, Neufeldt CJ, Cerikan B, Prasad V, et al
    A Versatile Reporter System to Monitor Virus Infected Cells and Its Application to Dengue Virus and SARS-CoV-2.
    J Virol. 2020 Nov 30. pii: JVI.01715-20. doi: 10.1128/JVI.01715.
    >> Share

  73. YUAN LX, Liang JQ, Zhu QC, Dai G, et al
    Gammacoronavirus Avian Infectious Bronchitis Virus and Alphacoronavirus Porcine Epidemic Diarrhea Virus Exploit a Cell-Survival Strategy via Upregulation of cFOS to Promote Viral Replication.
    J Virol. 2020 Nov 25. pii: JVI.02107-20. doi: 10.1128/JVI.02107.
    >> Share

  74. WESTERGREN JAKOBSSON A, Segerman B, Wallerman O, Lind SB, et al
    The Human Adenovirus Type 2 Transcriptome: An Amazing Complexity of Alternatively Spliced mRNAs.
    J Virol. 2020 Nov 25. pii: JVI.01869-20. doi: 10.1128/JVI.01869.
    >> Share

  75. CLARK LK, Green TJ, Petit CM
    Structure of nonstructural protein 1 from SARS-CoV-2.
    J Virol. 2020 Nov 24. pii: JVI.02019-20. doi: 10.1128/JVI.02019.
    >> Share

  76. MILEWSKA A, Chi Y, Szczepanski A, Barreto-Duran E, et al
    HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV.
    J Virol. 2020 Nov 20. pii: JVI.01622-20. doi: 10.1128/JVI.01622.
    >> Share

  77. UJIKE M, Kawachi Y, Matsunaga Y, Etho Y, et al
    Characterization of localization and export signals of bovine torovirus nucleocapsid protein responsible for extensive nuclear and nucleolar accumulation and their importance for virus growth.
    J Virol. 2020 Nov 11. pii: JVI.02111-20. doi: 10.1128/JVI.02111.
    >> Share

  78. TANDON R, Sharp JS, Zhang F, Pomin VH, et al
    Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives.
    J Virol. 2020 Nov 10. pii: JVI.01987-20. doi: 10.1128/JVI.01987.
    >> Share

  79. ALHAMMAD YMO, Kashipathy MM, Roy A, Gagne JP, et al
    The SARS-CoV-2 conserved macrodomain is a mono-ADP-ribosylhydrolase.
    J Virol. 2020 Nov 6. pii: JVI.01969-20. doi: 10.1128/JVI.01969.
    >> Share

  80. FENWICK C, Croxatto A, Coste AT, Pojer F, et al
    Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence Studies.
    J Virol. 2020 Nov 3. pii: JVI.01828-20. doi: 10.1128/JVI.01828.
    >> Share

  81. HEISE M, Dermody TS, Casadevall A, Sandri-Goldin RM, et al
    The Decision to Publish Gutierrez-Alvarez et al., "Middle East Respiratory Syndrome Coronavirus Gene 5 Modulates Pathogenesis in Mice".
    J Virol. 2020 Nov 3. pii: JVI.02118-20. doi: 10.1128/JVI.02118.
    >> Share

  82. GUTIERREZ-ALVAREZ J, Wang L, Fernandez-Delgado R, Li K, et al
    Middle East Respiratory Syndrome Coronavirus Gene 5 Modulates Pathogenesis in Mice.
    J Virol. 2020 Nov 3. pii: JVI.01172-20. doi: 10.1128/JVI.01172.
    >> Share

    October 2020
  83. DIEZ-FUERTES F, Iglesias-Caballero M, Garcia Perez J, Monzon S, et al
    A FOUNDER EFFECT LED EARLY SARS-COV-2 TRANSMISSION IN SPAIN.
    J Virol. 2020 Oct 30. pii: JVI.01583-20. doi: 10.1128/JVI.01583.
    >> Share

  84. MATSUYAMA S, Kawase M, Nao N, Shirato K, et al
    The inhaled steroid ciclesonide blocks SARS-CoV-2 RNA replication by targeting the viral replication-transcription complex in cultured cells.
    J Virol. 2020 Oct 14. pii: JVI.01648-20. doi: 10.1128/JVI.01648.
    >> Share

  85. LI Y, Yang N, Chen J, Huang X, et al
    Next-Generation Porcine Intestinal Organoids: an Apical-Out Organoid Model for Swine Enteric Virus Infection and Immune Response Investigations.
    J Virol. 2020;94.
    >> Share

    September 2020
  86. SYAGE AR, Ekiz HA, Skinner DD, Stone C, et al
    Single-cell RNA sequencing reveals the diversity of the immunological landscape following CNS infection by a murine coronavirus.
    J Virol. 2020 Sep 30. pii: JVI.01295-20. doi: 10.1128/JVI.01295.
    >> Share

  87. HU Y, Li W, Gao T, Cui Y, et al
    Correction for Hu et al., "The Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Inhibits Type I Interferon Production by Interfering with TRIM25-Mediated RIG-I Ubiquitination".
    J Virol. 2020;94.
    >> Share

  88. XU S, Zhou J, Chen Y, Tong X, et al
    Characterization of Self-Processing Activities and Substrate Specificities of Porcine Torovirus 3C-Like Protease.
    J Virol. 2020;94.
    >> Share

  89. CHOI JA, Goo J, Yang E, Jung DI, et al
    Cross-Protection against MERS-CoV by Prime-Boost Vaccination Using Viral Spike DNA and Protein.
    J Virol. 2020 Sep 23. pii: JVI.01176-20. doi: 10.1128/JVI.01176.
    >> Share

  90. OGANDO NS, Zevenhoven-Dobbe JC, van der Meer Y, Bredenbeek PJ, et al
    The enzymatic activity of the nsp14 exoribonuclease is critical for replication of MERS-CoV and SARS-CoV-2.
    J Virol. 2020 Sep 16. pii: JVI.01246-20. doi: 10.1128/JVI.01246.
    >> Share

  91. LOKUGAMAGE KG, Hage A, de Vries M, Valero-Jimenez AM, et al
    Type I interferon susceptibility distinguishes SARS-CoV-2 from SARS-CoV.
    J Virol. 2020 Sep 16. pii: JVI.01410-20. doi: 10.1128/JVI.01410.
    >> Share

  92. CHANDRASEKAR SS, Kingstad-Bakke B, Wu CW, Suresh M, et al
    A Novel Mucosal Adjuvant System for Immunization against Avian Coronavirus Causing Infectious Bronchitis.
    J Virol. 2020;94.
    >> Share

  93. BROCATO RL, Principe LM, Kim RK, Zeng X, et al
    Disruption of Adaptive Immunity Enhances Disease in SARS-CoV-2 Infected Syrian Hamsters.
    J Virol. 2020 Sep 8. pii: JVI.01683-20. doi: 10.1128/JVI.01683.
    >> Share

    August 2020
  94. LI Y, Wang H, Tang X, Fang S, et al
    SARS-CoV-2 and three related coronaviruses utilize multiple ACE2 orthologs and are potently blocked by an improved ACE2-Ig.
    J Virol. 2020 Aug 26. pii: JVI.01283-20. doi: 10.1128/JVI.01283.
    >> Share

  95. FROGGATT HM, Heaton BE, Heaton NS
    Development of a fluorescence based, high-throughput SARS-CoV-2 3CL(pro) reporter assay.
    J Virol. 2020 Aug 25. pii: JVI.01265-20. doi: 10.1128/JVI.01265.
    >> Share

  96. GUAN H, Wang Y, Perculija V, Saeed AFUH, et al
    Cryo-electron microscopy structure of the SADS-CoV spike glycoprotein provides insights into an evolution of unique coronavirus spike proteins.
    J Virol. 2020 Aug 19. pii: JVI.01301-20. doi: 10.1128/JVI.01301.
    >> Share

  97. WESTON S, Coleman CM, Haupt R, Logue J, et al
    Broad anti-coronaviral activity of FDA approved drugs against SARS-CoV-2 in vitro and SARS-CoV in vivo.
    J Virol. 2020 Aug 19. pii: JVI.01218-20. doi: 10.1128/JVI.01218.
    >> Share

  98. SI F, Chen B, Hu X, Yu R, et al
    Porcine Epidemic Diarrhea Virus ORF3 Protein Is Transported through the Exocytic Pathway.
    J Virol. 2020;94.
    >> Share

  99. HWANG M, Bergmann CC
    Neuronal ablation of IFNalpha/beta signaling exacerbates CNS viral dissemination and impairs IFNgamma responsiveness in microglia/macrophages.
    J Virol. 2020 Aug 12. pii: JVI.00422-20. doi: 10.1128/JVI.00422.
    >> Share

  100. JOHNSON MC, Lyddon TD, Suarez R, Salcedo B, et al
    Optimized pseudotyping conditions for the SARS COV-2 Spike glycoprotein.
    J Virol. 2020 Aug 11. pii: JVI.01062-20. doi: 10.1128/JVI.01062.
    >> Share

    July 2020
  101. GUO H, Hu BJ, Yang XL, Zeng LP, et al
    Evolutionary arms race between virus and host drives genetic diversity in bat SARS related coronavirus spike genes.
    J Virol. 2020 Jul 22. pii: JVI.00902-20. doi: 10.1128/JVI.00902.
    >> Share

  102. VANDERHEIDEN A, Ralfs P, Chirkova T, Upadhyay AA, et al
    Type I and Type III IFN Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
    J Virol. 2020 Jul 22. pii: JVI.00985-20. doi: 10.1128/JVI.00985.
    >> Share

  103. WANG Y, Sun J, Li X, Zhu A, et al
    Increased Pathogenicity and Virulence of Middle East Respiratory Syndrome Coronavirus Clade B In Vitro and In Vivo.
    J Virol. 2020;94.
    >> Share

  104. AHLEN G, Frelin L, Nekoyan N, Weber F, et al
    The SARS-CoV-2 N protein is a good component in a vaccine.
    J Virol. 2020 Jul 13. pii: JVI.01279-20. doi: 10.1128/JVI.01279.
    >> Share

  105. ZHAO X, Chen D, Szabla R, Zheng M, et al
    Broad and differential animal ACE2 receptor usage by SARS-CoV-2.
    J Virol. 2020 Jul 13. pii: JVI.00940-20. doi: 10.1128/JVI.00940.
    >> Share

  106. SMITH M, Honce R, Schultz-Cherry S
    Metabolic Syndrome and Viral Pathogenesis: Lessons from Influenza and Coronaviruses.
    J Virol. 2020 Jul 13. pii: JVI.00665-20. doi: 10.1128/JVI.00665.
    >> Share

  107. TABOADA B, Vazquez-Perez JA, Munoz Medina JE, Ramos Cervantes P, et al
    Genomic Analysis of Early SARS-CoV-2 Variants Introduced in Mexico.
    J Virol. 2020 Jul 8. pii: JVI.01056-20. doi: 10.1128/JVI.01056.
    >> Share

  108. ZHAO X, Zheng S, Chen D, Zheng M, et al
    LY6E Restricts the Entry of Human Coronaviruses, Including the Currently Pandemic SARS-CoV-2.
    J Virol. 2020 Jul 8. pii: JVI.00562-20. doi: 10.1128/JVI.00562.
    >> Share

  109. DERVAS E, Hepojoki J, Smura T, Prahauser B, et al
    Serpentoviruses, more than respiratory pathogens.
    J Virol. 2020 Jul 8. pii: JVI.00649-20. doi: 10.1128/JVI.00649.
    >> Share

  110. CHAKRAVARTY D, Saadi F, Kundu S, Bose A, et al
    CD4 Deficiency Causes Poliomyelitis and Axonal Blebbing in Murine Coronavirus-Induced Neuroinflammation.
    J Virol. 2020;94.
    >> Share

  111. DALMANN A, Reimann I, Wernike K, Beer M, et al
    Autonomously Replicating RNAs of Bungowannah Pestivirus: E(RNS) Is Not Essential for the Generation of Infectious Particles.
    J Virol. 2020;94.
    >> Share

  112. YIN L, Chen J, Li L, Guo S, et al
    Aminopeptidase N Expression, Not Interferon Responses, Determines the Intestinal Segmental Tropism of Porcine Deltacoronavirus.
    J Virol. 2020;94.
    >> Share

    June 2020
  113. MOORE JP, Klasse PJ
    SARS-CoV-2 vaccines: 'Warp Speed' needs mind melds not warped minds.
    J Virol. 2020 Jun 26. pii: JVI.01083-20. doi: 10.1128/JVI.01083.
    >> Share

  114. LIU Z, Zheng H, Lin H, Li M, et al
    Identification of common deletions in the spike protein of SARS-CoV-2.
    J Virol. 2020 Jun 22. pii: JVI.00790-20. doi: 10.1128/JVI.00790.
    >> Share

  115. DENG X, Buckley AC, Pillatzki A, Lager KM, et al
    Inactivating Three Interferon Antagonists Attenuates Pathogenesis of an Enteric Coronavirus.
    J Virol. 2020 Jun 17. pii: JVI.00565-20. doi: 10.1128/JVI.00565.
    >> Share

  116. DUTTA NK, Mazumdar K, Gordy JT
    The Nucleocapsid Protein of SARS-CoV-2: a Target for Vaccine Development.
    J Virol. 2020;94.
    >> Share

  117. STRAUS MR, Tang T, Lai AL, Flegel A, et al
    Ca(2+) Ions Promote Fusion of Middle East Respiratory Syndrome Coronavirus with Host Cells and Increase Infectivity.
    J Virol. 2020;94.
    >> Share

  118. CHANG CY, Liu HM, Chang MF, Chang SC, et al
    Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Suppresses Type I and Type III Interferon Induction by Targeting RIG-I Signaling.
    J Virol. 2020;94.
    >> Share

    May 2020
  119. LU Y, Cai H, Lu M, Ma Y, et al
    Porcine epidemic diarrhea virus deficient in RNA cap guanine-N-7 methylation is attenuated and induces higher type I and III interferon responses.
    J Virol. 2020 May 27. pii: JVI.00447-20. doi: 10.1128/JVI.00447.
    >> Share

  120. ZHU X, Chen J, Tian L, Zhou Y, et al
    Porcine Deltacoronavirus nsp5 Cleaves DCP1A to Decrease Its Antiviral Ability.
    J Virol. 2020 May 27. pii: JVI.02162-19. doi: 10.1128/JVI.02162.
    >> Share

  121. MILEWSKA A, Kula-Pacurar A, Wadas J, Suder A, et al
    Replication of SARS-CoV-2 in human respiratory epithelium.
    J Virol. 2020 May 20. pii: JVI.00957-20. doi: 10.1128/JVI.00957.
    >> Share

  122. VOLK A, Hackbart M, Deng X, Cruz-Pulido Y, et al
    Coronavirus Endoribonuclease and Deubiquitinating Interferon Antagonists Differentially Modulate the Host Response during Replication in Macrophages.
    J Virol. 2020;94.
    >> Share

  123. DENG X, Chen Y, Mielech AM, Hackbart M, et al
    Structure-Guided Mutagenesis Alters Deubiquitinating Activity and Attenuates Pathogenesis of a Murine Coronavirus.
    J Virol. 2020;94.
    >> Share

  124. ZHAI X, Sun J, Yan Z, Zhang J, et al
    Comparison of SARS-CoV-2 spike protein binding to ACE2 receptors from human, pets, farm animals, and putative intermediate hosts.
    J Virol. 2020 May 13. pii: JVI.00831-20. doi: 10.1128/JVI.00831.
    >> Share

  125. ZHU Y, Yu D, Yan H, Chong H, et al
    Design of potent membrane fusion inhibitors against SARS-CoV-2, an emerging coronavirus with high fusogenic activity.
    J Virol. 2020 May 6. pii: JVI.00635-20. doi: 10.1128/JVI.00635.
    >> Share

  126. HOLLAND LA, Kaelin EA, Maqsood R, Estifanos B, et al
    An 81 nucleotide deletion in SARS-CoV-2 ORF7a identified from sentinel surveillance in Arizona (Jan-Mar 2020).
    J Virol. 2020 May 1. pii: JVI.00711-20. doi: 10.1128/JVI.00711.
    >> Share

    April 2020
  127. NGUYEN A, David JK, Maden SK, Wood MA, et al
    Human leukocyte antigen susceptibility map for SARS-CoV-2.
    J Virol. 2020 Apr 17. pii: JVI.00510-20. doi: 10.1128/JVI.00510.
    >> Share

  128. WANG M, Li M, Ren R, Li L, et al
    International expansion of a novel SARS-CoV-2 mutant.
    J Virol. 2020 Apr 8. pii: JVI.00567-20. doi: 10.1128/JVI.00567.
    >> Share

  129. LICASTRO D, Rajasekharan S, Dal Monego S, Segat L, et al
    Isolation and full-length genome characterization of SARS-CoV-2 from COVID-19 cases in Northern Italy.
    J Virol. 2020 Apr 1. pii: JVI.00543-20. doi: 10.1128/JVI.00543.
    >> Share

  130. CAGLIANI R, Forni D, Clerici M, Sironi M, et al
    Computational inference of selection underlying the evolution of the novel coronavirus, SARS-CoV-2.
    J Virol. 2020 Apr 1. pii: JVI.00411-20. doi: 10.1128/JVI.00411.
    >> Share

    January 2020
  131. WAN Y, Shang J, Graham R, Baric RS, et al
    Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS.
    J Virol. 2020 Jan 29. pii: JVI.00127-20. doi: 10.1128/JVI.00127.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016